🇺🇸 Non ionic contrast media comparator in United States

FDA authorised Non ionic contrast media comparator on 22 March 1996

Marketing authorisations

FDA — authorised 22 March 1996

  • Application: NDA020351
  • Marketing authorisation holder: GE HEALTHCARE
  • Local brand name: VISIPAQUE 320
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 29 August 1997

  • Application: NDA020808
  • Marketing authorisation holder: GE HEALTHCARE
  • Local brand name: VISIPAQUE 320
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

Other Diagnostic Imaging approved in United States

Frequently asked questions

Is Non ionic contrast media comparator approved in United States?

Yes. FDA authorised it on 22 March 1996; FDA authorised it on 29 August 1997.

Who is the marketing authorisation holder for Non ionic contrast media comparator in United States?

GE HEALTHCARE holds the US marketing authorisation.